# Clinical Validation of a Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer (VERIFI)

> **NCT06947395** · — · COMPLETED · sponsor: **Immunovia, Inc.** · enrollment: 386 (actual)

## Conditions studied

- Cancer of the Pancreas
- Pancreatic Cancer
- Pancreas Neoplasms
- Pancreatic Carcinoma Stage I
- Pancreatic Carcinoma Stage II

## Interventions

- **DIAGNOSTIC_TEST:** PancreaSure

## Key facts

- **NCT ID:** NCT06947395
- **Lead sponsor:** Immunovia, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-11
- **Primary completion:** 2025-03-24
- **Final completion:** 2025-04-07
- **Target enrollment:** 386 (ACTUAL)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06947395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06947395, "Clinical Validation of a Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer (VERIFI)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06947395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*